18:36 , Apr 26, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 17 profitable biotechs and pharmas are slated to report earnings this week. (A) Fiscal 2Q; (B) During trading hours in Europe; premarket on U.S. exchange Company Date Pre/post mkt 1Q19...
23:09 , Mar 29, 2019 |  BC Extra  |  Company News

Management tracks: Insmed, AACR, BlueRock

Pulmonary disease company Insmed said Paolo Tombesi will step down as CFO and remain a consultant, effective June 2. Insmed Inc. (NASDAQ:INSM) will begin to search for a successor. It also promoted John Goll to...
00:04 , Feb 16, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck Company Date Pre/post mkt 4Q18 EPS est 4Q17 EPS Expected chg NeoGenomics Inc. (NASDAQ:NEO) 2/19 Pre $0.05 $0.05 0% Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC) 2/20 Pre $0.84 $0.98 -14% Genmab A/S...
23:30 , Oct 19, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 11 profitable biotechs and pharmas are slated to report earnings this week. (A) Fiscal 2Q Company Date Pre/post mkt 3Q18 EPS est 3Q17 EPS Expected chg Biogen Inc. (NASDAQ:BIIB) 10/23...
23:37 , Jul 20, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 18 profitable biotechs and pharmas are slated to report earnings this week. (A) Six-month EPS figures; (B) Fiscal 1Q Company Date Pre/post mkt 2Q18 EPS est 2Q17 EPS Expected chg...
18:25 , Jun 22, 2018 |  BC Week In Review  |  Clinical News

Anika's Cingal misses in Phase III for osteoarthritis knee pain

Anika Therapeutics Inc. (NASDAQ:ANIK) reported that Cingal missed the primary endpoint in the Phase III 16-02 trial to treat pain associated with osteoarthritis (OA) of the knee. Cingal comprises a single injection of sodium hyaluronate...
01:53 , Jun 20, 2018 |  BC Extra  |  Clinical News

Anika's Cingal misses in Phase III for osteoarthritis knee pain

Anika Therapeutics Inc. (NASDAQ:ANIK) was off $9.62 (21%) to $36.50 in after-hours trading Tuesday after reporting that Cingal missed the primary endpoint in the Phase III 16-02 trial to treat pain associated with OA of...
20:32 , Apr 27, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 14 profitable biotechs and pharmas are slated to report earnings this week. (A) During trading hours in Tel Aviv, before U.S. exchanges open Company Date Pre/post mkt 1Q18 EPS est...
00:19 , Mar 7, 2018 |  BC Extra  |  Company News

Management tracks: Alliance, Anika

Alliance Pharma plc (LSE:APH) said CEO John Dawson will step down, effective May 1. He will be succeeded by Deputy CEO Peter Butterfield. The company also said Chairman Andrew Smith has stepped down. Smith is...
22:59 , Feb 16, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least six profitable biotechs and pharmas are slated to report earnings this week. (A) 12-month EPS Company Date Pre/post mkt 4Q17 EPS est 4Q16 EPS Expected chg United Therapeutics Corp. (NASDAQ:UTHR)...